KEY FEATURES
| Full Name | Growth Differentiation Factor 9 |
|---|---|
| Synonym | GDF9 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.6-1000pg/mL |
| Sensitivity | 5.7pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human GDF9 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human GDF9. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human GDF9 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human GDF9, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human GDF9. You can calculate the concentration of Human GDF9 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human GDF9 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 49.77 | 117.56 | 376.32 | 48.8 | 125.35 | 407.43 |
| Standard deviation | 3.43 | 6.43 | 20.66 | 2.56 | 6.23 | 19.39 |
| CV(%) | 6.89 | 5.47 | 5.49 | 5.24 | 4.97 | 4.76 |
RECOVERY
The recovery of Human GDF9 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 92-106 | 99 |
| EDTA plasma (n=8) | 88-100 | 94 |
| Cell culture media (n=8) | 91-106 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human GDF9 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with GDF9 ELISA Kits
| BMPR2 ELISA Kit | publications with GDF9 and BMPR2 |
| KITLG ELISA Kit | publications with GDF9 and KITLG |
| SMAD2 ELISA Kit | publications with GDF9 and SMAD2 |
| HAS2 ELISA Kit | publications with GDF9 and HAS2 |
| PTGS2 ELISA Kit | publications with GDF9 and PTGS2 |
| ZAR1 ELISA Kit | publications with GDF9 and ZAR1 |
| LHCGR ELISA Kit | publications with GDF9 and LHCGR |
| FSHR ELISA Kit | publications with GDF9 and FSHR |
| TGFBR1 ELISA Kit | publications with GDF9 and TGFBR1 |
Pathways associated with GDF9 ELISA Kit
| Ovarian Infertility Genes Pathway | Ovarian Infertility Genes Pathway |
| Ovarian Steroidogenesis Pathway | Ovarian Steroidogenesis Pathway |
Diseases associated with GDF9 ELISA Kit
| Ovarian Diseases | publications with GDF9 and Ovarian Diseases |
| Infertility, Female | publications with GDF9 and Infertility, Female |
| Polycystic Ovary Syndrome | publications with GDF9 and Polycystic Ovary Syndrome |
| Infertility, Male | publications with GDF9 and Infertility, Male |
| Congenital Abnormalities | publications with GDF9 and Congenital Abnormalities |
| Necrosis | publications with GDF9 and Necrosis |
| Kidney Diseases | publications with GDF9 and Kidney Diseases |
| Urogenital Abnormalities | publications with GDF9 and Urogenital Abnormalities |
| Disorders of Sex Development | publications with GDF9 and Disorders of Sex Development |
| Adenocarcinoma | publications with GDF9 and Adenocarcinoma |
Organs/Tissues associated with GDF9 ELISA Kit
| Testis | publications with GDF9 and Testis |
| Kidney | publications with GDF9 and Kidney |
| Brain | publications with GDF9 and Brain |
| Liver | publications with GDF9 and Liver |
| Adrenal Gland | publications with GDF9 and Adrenal Gland |
| Mammary Gland | publications with GDF9 and Mammary Gland |